Latest Breaking News On - Pharmalytics corporation - Page 1 : comparemela.com

Study on Philippines 1st dengue cure expected to be completed by 2022 —project head

Study on Philippines 1st dengue cure expected to be completed by 2022 —project head
gmanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gmanetwork.com Daily Mail and Mail on Sunday newspapers.

Technology philippine council for health researchDepartment of scienceDepartment of healthPharmalytics corporationRita grace alveroPhilippine councilHealth research

What you need to know about PH s first-ever definitive treatment for dengue – Manila Bulletin

The second and third phases of the clinical study on the safety and efficacy of the plant-based anti-dengue drug will start in September this year, and "will be completed within a year", the Department of Science and Technology (DOST) said on Friday, Aug. 20. (MANILA BULLETIN FILE PHOTO) DOST U

Cavite cityRowena cristinal guevaraJosefino alveroUndersecretary for researchPhilippine council for health researchDepartment of scienceDepartment of healthPharmalytics corporationDevelopment rd drRowena cristinaPlacebo controlled trialPhilippine councilHealth researchகாயிதே நகரம்பிலிப்பைன் சபை க்கு ஆரோக்கியம் ஆராய்ச்சிதுறை ஆஃப் அறிவியல்

Potential dengue medicine set for phase 2 clinical trials

Potential dengue medicine set for phase 2 clinical trials enablePagination: false endIndex: Metro Manila (CNN Philippines, January 16) – A potential cure for dengue is about to undergo phase 2 clinical trials this year, Philippine Council for Health Research and Development Executive Director Jaime Montoya said on Friday. Montoya said around 600 volunteers will take part in the trials in Cavite that will last for about 10 months. He said the anti-dengue drug is made of three endemic herbal plants from local company Pharmalytics Corporation. The research is also funded by the Department of Science and Technology. “We will investigate this drug by lowering the viral load, reducing viral leakage, and improvement of platelet formation,” said Montoya in the virtual DOST report.

Cavite cityMetro manilaPhilippines generalJaime montoyaPhilippine council for health researchDepartment of sciencePharmalytics corporationPhilippine councilHealth researchDevelopment executive director jaime montoyaகாயிதே நகரம்மெட்ரோ மணிலாபிலிப்பைன்ஸ் ஜநரல்ஜெய்ம் மோன்டோயாபிலிப்பைன் சபை க்கு ஆரோக்கியம் ஆராய்ச்சிதுறை ஆஃப் அறிவியல்